Published on 22 May 2024 on Simply Wall St. via Yahoo Finance
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 60% of...
Key Insights
Significantly high institutional ownership implies Black Diamond Therapeutics' stock price is sensitive to their trading actionsA total of 5 investors have a majority stake in the company with 55% ownership Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business
Every investor in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) should be aware of the most powerful shareholder groups. With 60% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).